FUJIFILM Holdings Corporation (FUJIY - Free Report) reported a third-quarter (ended Dec 31, 2021) net income of ¥60.8 billion compared with ¥58.9 billion in the year-ago quarter.
Revenues of ¥655.8 billion increased 13.8% year over year.
Segment Details
Healthcare segment revenues were ¥201.1 billion, up 43.6% from the year-ago quarter’s levels.
Medical Systems revenues rose 52.8% year over year to ¥134.8 billion. Bio CDMO revenues surged 47.4% year over year to ¥37.4 billion. Life sciences revenues were ¥28.9 billion, up 9.2% year over year.
Materials' segment's revenues increased 8.5% to ¥158.4 billion. Electronic Materials, Graphic communication and other high-functioning materials revenues increased 23.6%, 9% and 11.7% on a year-over-year basis, respectively. Display Materials revenues fell 12.4% year over year.
The Business Innovation Solutions segment’s revenues were ¥184.3 billion, down 0.4% from the year-ago quarter’s figure. Office solutions revenues dropped 1.4% and Business solutions revenues increased 1.6% on a year-over-year basis, respectively.
The Imaging Solutions segment’s revenues were ¥111.9 billion, up 6.8% from the year-ago quarter’s levels. Consumer Imaging and Professional Imaging revenues rose 3.7% and 14.9% on a year-over-year basis, respectively.
Operating Details
Selling, general and administrative expenses increased 6.5% to ¥163.4 billion. Research and development dropped 0.5% to ¥36.2 billion.
Operating income rose 22.8% year over year to ¥78.6 billion.
Balance Sheet & Cash Flow
As of Dec 31, 2021, cash and cash equivalents were ¥425 billion, up from ¥433.5 billion as of Sep 30, 2021.
Total debt was ¥472.7 billion as of Dec 31, 2021, compared with ¥499.1 billion as of Sep 30, 2021.
Guidance
FUJIFILM expects revenues of ¥2,510 billion for the year ending Mar 31, 2022, indicating growth of 14.5% year over year. Operating income is projected at ¥225 billion, up 36% year over year. Net income is expected to increase 2.1% year over year to ¥185 billion.
Zacks Rank & Other Stocks to Consider
Currently, FUJIFILM has a Zacks Rank #3 (Hold).
Some other top-ranked stocks worth consideration from the broader technology sector include Broadcom (AVGO - Free Report) , Apple (AAPL - Free Report) and Cadence Design Systems (CDNS - Free Report) . While Apple sports a Zacks Rank #1 (Strong Buy), Broadcom and Cadence carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Broadcom’s fiscal 2022 earnings is pegged at $33.03 per share. The long-term earnings growth rate of the company is pegged at 14.5%.
Broadcom’s earnings beat the Zacks Consensus Estimate in all the preceding four quarters, the average surprise being 1.41%. Shares of Broadcom have increased 31.4% in the past year.
The Zacks Consensus Estimate for Apple’s fiscal 2022 earnings is pegged at $6.15 per share. The long-term earnings growth rate of the company is pegged at 12.5%.
Apple’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 20.3%. Shares of AAPL have rallied 29.9% in the past year.
The Zacks Consensus Estimate for Cadence 2021 earnings is pegged at $3.25 per share. The long-term earnings growth rate of the company is pegged at 18.2%.
Cadence’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 11%. Shares of CDNS have returned 7.6% in the past year.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
FUJIFILM Holdings Corporation (FUJIY - Free Report) reported a third-quarter (ended Dec 31, 2021) net income of ¥60.8 billion compared with ¥58.9 billion in the year-ago quarter.
Revenues of ¥655.8 billion increased 13.8% year over year.
Segment Details
Healthcare segment revenues were ¥201.1 billion, up 43.6% from the year-ago quarter’s levels.
Medical Systems revenues rose 52.8% year over year to ¥134.8 billion. Bio CDMO revenues surged 47.4% year over year to ¥37.4 billion. Life sciences revenues were ¥28.9 billion, up 9.2% year over year.
Materials' segment's revenues increased 8.5% to ¥158.4 billion. Electronic Materials, Graphic communication and other high-functioning materials revenues increased 23.6%, 9% and 11.7% on a year-over-year basis, respectively. Display Materials revenues fell 12.4% year over year.
The Business Innovation Solutions segment’s revenues were ¥184.3 billion, down 0.4% from the year-ago quarter’s figure. Office solutions revenues dropped 1.4% and Business solutions revenues increased 1.6% on a year-over-year basis, respectively.
The Imaging Solutions segment’s revenues were ¥111.9 billion, up 6.8% from the year-ago quarter’s levels. Consumer Imaging and Professional Imaging revenues rose 3.7% and 14.9% on a year-over-year basis, respectively.
Operating Details
Selling, general and administrative expenses increased 6.5% to ¥163.4 billion. Research and development dropped 0.5% to ¥36.2 billion.
Operating income rose 22.8% year over year to ¥78.6 billion.
Balance Sheet & Cash Flow
As of Dec 31, 2021, cash and cash equivalents were ¥425 billion, up from ¥433.5 billion as of Sep 30, 2021.
Total debt was ¥472.7 billion as of Dec 31, 2021, compared with ¥499.1 billion as of Sep 30, 2021.
Guidance
FUJIFILM expects revenues of ¥2,510 billion for the year ending Mar 31, 2022, indicating growth of 14.5% year over year. Operating income is projected at ¥225 billion, up 36% year over year. Net income is expected to increase 2.1% year over year to ¥185 billion.
Zacks Rank & Other Stocks to Consider
Currently, FUJIFILM has a Zacks Rank #3 (Hold).
Some other top-ranked stocks worth consideration from the broader technology sector include Broadcom (AVGO - Free Report) , Apple (AAPL - Free Report) and Cadence Design Systems (CDNS - Free Report) . While Apple sports a Zacks Rank #1 (Strong Buy), Broadcom and Cadence carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Broadcom’s fiscal 2022 earnings is pegged at $33.03 per share. The long-term earnings growth rate of the company is pegged at 14.5%.
Broadcom’s earnings beat the Zacks Consensus Estimate in all the preceding four quarters, the average surprise being 1.41%. Shares of Broadcom have increased 31.4% in the past year.
The Zacks Consensus Estimate for Apple’s fiscal 2022 earnings is pegged at $6.15 per share. The long-term earnings growth rate of the company is pegged at 12.5%.
Apple’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 20.3%. Shares of AAPL have rallied 29.9% in the past year.
The Zacks Consensus Estimate for Cadence 2021 earnings is pegged at $3.25 per share. The long-term earnings growth rate of the company is pegged at 18.2%.
Cadence’s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 11%. Shares of CDNS have returned 7.6% in the past year.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Get the latest research report on AAPL - FREE
Get the latest research report on FUJIY - FREE
Get the latest research report on AVGO - FREE
Get the latest research report on CDNS - FREE